ULIHF Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 des 2023 @ 15:39):

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products...

Stats
Dagens volum	100.00
Gjennomsnittsvolum	0.00
Markedsverdi	1.62B
Neste inntjeningsdato	( $0 ) 2024-06-19
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	5.26
ATR14	$0.00400 (0.45%)

Volum Korrelasjon

Lang: 0.05 (neutral)

Kort: 0.00 (neutral)

Signal:(99.078) Neutral

The United Laboratories Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

The United Laboratories Korrelasjon - Valuta/Råvare

-0.81
( strong negative )

-0.36
( neutral )

0.00
( neutral )

-0.27
( neutral )

-0.55
( weak negative )

0.22
( neutral )

The United Laboratories Økonomi

Annual	2023
Omsetning:	$13.74B
Bruttogevinst:	$6.33B (46.11 %)
EPS:	$1.490

FY	2023
Omsetning:	$13.74B
Bruttogevinst:	$6.33B (46.11 %)
EPS:	$1.490

FY	2022
Omsetning:	$11.33B
Bruttogevinst:	$4.97B (43.84 %)
EPS:	$0.870

Financial Reports:

No articles found.

The United Laboratories Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

The United Laboratories

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.